Gene Therapy in Brain Tumours: Implications of the Size of Glioblastoma on its Curability

Acta Neurochirurgica, Supplement

Volumn 1997, Issue 68, 1997, Pages 111-117

  Izquierdo, M ^a   Cortes M L ^a   Martin V ^a   De Felipe, P ^a   Izquierdo, J M ^b   Perez Higueras A ^c   Paz, J F ^d   Isla, A ^d   Blazquez M G ^d  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c Clin Concepcion   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Gene therapy; Glioblastoma; Hstk ganciclovir system; Tumour size curability

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ANIMAL; ARTICLE; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; CELL DEATH; GENE THERAPY; GENE TRANSFER; GENETICS; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HUMAN; MALE; METHODOLOGY; MORTALITY; MOUSE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RAT; SURVIVAL RATE; TUMOR RECURRENCE; WISTAR RAT;

ANIMALS; BRAIN NEOPLASMS; CELL DEATH; COMBINED MODALITY THERAPY; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLIOBLASTOMA; HUMANS; MALE; MICE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; PROGNOSIS; RATS; RATS, WISTAR; SIMPLEXVIRUS; SURVIVAL RATE; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0030634387     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6513-3_21     Document Type: Article

References (18)

1. Culver KW, Wallbridge S, Ishii H, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550-1552.
2. Culver K et al (1994) Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with herpes simplex thymidine kinase gene/ganciclovir system (clinical protocol). Hum Gene Ther 5: 343-379
3. Danos O (1991) Construction of retroviral packaging cell lines. Methods Mol Biol 8: 17-27
4. Elshami AA et al (1996) Gap junctions play a role in the "bystander effect" of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther 3: 85-92
5. Freeman SM et al (1993) The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53: 5274-5283
6. Izquierdo M Cortés M, de Felipe P, Martín V Diéz-Guerra J, Talavera A, Perez-Higueras A (1995) Long term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Ther 2: 66-69
7. Izquierdo M, Martín V, de Felipe P, Izquierdo JM, Pérez-Higueras A, Cortés ML, Paz JF, Isla A, Blázquez MG (1996) Human malignant brain tumor response to Herpes Simplex thimidine kinase (HSVtk)/ganciclovir gene therapy. Gene Ther 3: 491-495
8. Li Bi W, Parysek LM, Warnick R, Stambrook PJ (1993) In vitro evidence that metabolic cooperation is responsible for the bystander effect observed whith HSVtk retroviral gene therapy. Hum Gene Ther 4: 725-731
9. Miller AD, Miller DG, Garcia JV, Lynch CM (1993) Use of retroviral vectors for gene transfer and expression. Meth Enzymol 217: 581-599
10. Miller AD, Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980-990
11. Moolten FL (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res 46: 5276-5281
12. Morgenstern J, Land H (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nuc Acid Res 18: 3587-3596
13. Peterson DL, Sheridan PJ, Brown WE (1994) Animal models for brain tumors: historical perspectives and future directions. J Neurosurg 80: 865-876
14. Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH (1993) In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53: 83-88
15. Ram Z, Culver KW, Walbridge Frank JA, S, Blaese RM, Oldfield EH (1993) Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J Neurosurg 79: 400-407
16. Short MP, Choi BC, Lee JK, Malick A, Breakefield XO, Martuza RL (1990) Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res 27: 427-433
17. Takamiya Y, Short MP, Ezzeddine ZD, Moolten FL, Breakefield XO, Martuza RL (1992) Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 33: 493-503
18. Wu JK et al (1994) Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 35: 1094-1102